Files in This Item:


Title: Elimination of lymphatic filariasis in the South-East Asia Region : Report of the ninth meeting of the regional programme review group (RPRG) Yangon, Myanmar
Authors: World Health Organization, Regional Office for South-East Asia
Issue Date: 2012
Publisher: WHO Regional Office for South-East Asia
Place of publication: New Delhi
Language: English
Abstract: Description: Lymphatic filariasis (LF) is one of the leading causes of permanent disability affecting socioeconomic growth in many LF endemic countries. The WHO South-East Asia Region accounts for the highest burden of LF in 9 of its 11 Member States. The Ninth meeting of the Regional Programme Review Group (RPRG) for Elimination of Lymphatic Filariasis in the South-East Asia Region was held on 30 April to 1 May 2012, in Yangon, Myanmar. The meeting reviewed the progress of LF elimination in the Region, identified major issues and made technical and operational recommendations to scale-up mass drug administration (MDA) and morbidity management in endemic Member States. The meeting while appreciating the progress, approved a total of 710.7 million albendazole treatments for the 2012 MDA round out, of which 457.44 million will be supplied as donation by GSK through WHO. This report presents the synopsis
Gov't Doc #: SEA-CD-261
Appears in Collections:Meeting Reports

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.